Analysts’ updated eps estimates for Thursday, December 12th:
Abeona Therapeutics (NASDAQ:ABEO) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
Affimed (NASDAQ:AFMD) had its target price reduced by Wells Fargo & Company from $20.00 to $15.00. They currently have an overweight rating on the stock.
AnaptysBio (NASDAQ:ANAB) had its price target trimmed by Wells Fargo & Company from $56.00 to $40.00. The firm currently has an overweight rating on the stock.
AMREP (NYSE:AXR) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Baidu (NASDAQ:BIDU) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Costco Wholesale (NASDAQ:COST) had its target price raised by Evercore ISI from $1,019.00 to $1,020.00. They currently have an overweight rating on the stock.
Costco Wholesale (NASDAQ:COST) had its target price raised by UBS Group AG from $840.00 to $1,040.00. The firm currently has a buy rating on the stock.
Costco Wholesale (NASDAQ:COST) had its price target increased by Raymond James from $990.00 to $1,030.00. Raymond James currently has an overweight rating on the stock.
Equinor ASA (NYSE:EQNR) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.
Hooker Furnishings (NASDAQ:HOFT) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
iTeos Therapeutics (NASDAQ:ITOS) had its outperform rating reissued by analysts at Wedbush. They currently have a $25.00 target price on the stock.
Insulet (NASDAQ:PODD) had its target price boosted by JPMorgan Chase & Co. from $280.00 to $330.00. They currently have an overweight rating on the stock.
Star Bulk Carriers (NASDAQ:SBLK) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
TXNM Energy (NYSE:TXNM) had its target price raised by Citigroup Inc. from $45.00 to $53.00. The firm currently has a neutral rating on the stock.
Vericel (NASDAQ:VCEL) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
Receive News & Ratings for Abeona Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
